Incorporation of a Novel CD16-Specific Single-Domain Antibody into Multispecific Natural Killer Cell Engagers With Potent ADCC.
Mol Pharm
; 18(6): 2375-2384, 2021 06 07.
Article
in En
| MEDLINE
| ID: mdl-33999642
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Recombinant Fusion Proteins
/
Killer Cells, Natural
/
Antibodies, Bispecific
/
Single-Domain Antibodies
/
Neoplasms
Limits:
Animals
/
Humans
Language:
En
Journal:
Mol Pharm
Year:
2021
Document type:
Article